"Intestinal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the INTESTINES.
Descriptor ID |
D007414
|
MeSH Number(s) |
C04.588.274.476.411 C06.301.371.411 C06.405.249.411 C06.405.469.491
|
Concept/Terms |
Intestinal Neoplasms- Intestinal Neoplasms
- Intestinal Neoplasm
- Neoplasm, Intestinal
- Neoplasms, Intestinal
- Intestines Neoplasms
- Intestines Neoplasm
- Neoplasm, Intestines
- Neoplasms, Intestines
Cancer of Intestines- Cancer of Intestines
- Intestines Cancers
- Cancer of the Intestines
- Intestines Cancer
- Cancer, Intestines
- Cancers, Intestines
- Intestinal Cancer
- Cancer, Intestinal
- Cancers, Intestinal
- Intestinal Cancers
|
Below are MeSH descriptors whose meaning is more general than "Intestinal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Intestinal Neoplasms".
This graph shows the total number of publications written about "Intestinal Neoplasms" by people in this website by year, and whether "Intestinal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 2 | 4 |
1996 | 1 | 0 | 1 |
1997 | 4 | 0 | 4 |
1998 | 1 | 0 | 1 |
1999 | 2 | 1 | 3 |
2000 | 2 | 0 | 2 |
2001 | 3 | 0 | 3 |
2003 | 3 | 2 | 5 |
2004 | 6 | 2 | 8 |
2005 | 1 | 1 | 2 |
2006 | 5 | 2 | 7 |
2007 | 4 | 1 | 5 |
2008 | 3 | 1 | 4 |
2009 | 3 | 0 | 3 |
2010 | 6 | 0 | 6 |
2011 | 1 | 1 | 2 |
2012 | 1 | 0 | 1 |
2013 | 4 | 1 | 5 |
2014 | 2 | 1 | 3 |
2015 | 2 | 0 | 2 |
2016 | 4 | 0 | 4 |
2017 | 4 | 0 | 4 |
2018 | 3 | 0 | 3 |
2019 | 5 | 0 | 5 |
2020 | 4 | 1 | 5 |
2021 | 5 | 0 | 5 |
2023 | 2 | 0 | 2 |
2024 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Intestinal Neoplasms" by people in Profiles.
-
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high-dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study. Lancet. 2024 Jun 29; 403(10446):2807-2817.
-
From the archives of MD Anderson Cancer Center: Monomorphic epitheliotropic intestinal T-cell lymphoma: A case with an unusual immunophenotype and discussion of differential diagnosis. Ann Diagn Pathol. 2024 Jun; 70:152293.
-
Liver Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms. J Comput Assist Tomogr. 2024 Jul-Aug 01; 48(4):577-587.
-
Dietary Folate and Cofactors Accelerate Age-dependent p16 Epimutation to Promote Intestinal Tumorigenesis. Cancer Res Commun. 2024 01 19; 4(1):164-169.
-
Small Bowel Neuroendocrine Neoplasms-A Review. J Comput Assist Tomogr. 2024 Jul-Aug 01; 48(4):563-576.
-
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting. J Natl Cancer Inst. 2023 09 07; 115(9):1001-1010.
-
Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis. Cancer Prev Res (Phila). 2021 09; 14(9):851-862.
-
Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapy. ESMO Open. 2021 06; 6(3):100132.
-
Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes Database. Pancreas. 2021 04 01; 50(4):506-512.
-
Early central nervous system relapse of monomorphic epitheliotropic intestinal T-cell lymphoma after cord blood transplantation. Int J Hematol. 2021 Jul; 114(1):129-135.